{
    "organizations": [],
    "uuid": "db6c3d75764d61797840153b3e0f1d0ad3c0a144",
    "author": "Reuters Editorial",
    "url": "https://www.reuters.com/article/brief-correvio-q1-loss-per-share-024/brief-correvio-q1-loss-per-share-0-24-idUSASC0A2DY",
    "ord_in_thread": 0,
    "title": "BRIEF-Correvio Q1 Loss Per Share $0.24",
    "locations": [],
    "highlightText": "",
    "language": "english",
    "persons": [],
    "text": "May 15 (Reuters) - Cardiome Pharma Corp:\n* Q1 LOSS PER SHARE $0.24 * Q1 EARNINGS PER SHARE VIEW $-0.22 â€” THOMSON REUTERS I/B/E/S\n* CORREVIO PHARMA CORP - AT MARCH 31, 2018, COMPANY HAD CASH AND CASH EQUIVALENTS OF $13.6 MILLION Source text for Eikon: Further company coverage:\nOur Standards: The Thomson Reuters Trust Principles. ",
    "published": "2018-05-16T04:10:00.000+03:00",
    "crawled": "2018-05-16T18:47:16.040+03:00",
    "highlightTitle": "",
    "preprocessed_text": [
        "may",
        "reuters",
        "cardiome",
        "pharma",
        "corp",
        "q1",
        "loss",
        "per",
        "share",
        "q1",
        "earnings",
        "per",
        "share",
        "view",
        "thomson",
        "reuters",
        "correvio",
        "pharma",
        "corp",
        "march",
        "company",
        "cash",
        "cash",
        "equivalent",
        "million",
        "source",
        "text",
        "eikon",
        "company",
        "coverage",
        "standard",
        "thomson",
        "reuters",
        "trust",
        "principle"
    ]
}